Eventide Asset Management - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 152 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2023$6,728,873
-32.0%
501,033
-37.4%
0.12%
-36.9%
Q4 2022$9,896,000
-11.3%
800,0000.0%0.20%
-11.4%
Q3 2022$11,160,000
+1.0%
800,0000.0%0.22%
-6.8%
Q2 2022$11,048,000
-15.1%
800,0000.0%0.24%
+15.7%
Q1 2022$13,016,000
+144.0%
800,000
+144.3%
0.20%
+200.0%
Q4 2021$5,334,000
-57.0%
327,444
+227.4%
0.07%
-80.5%
Q4 2019$12,392,000
-46.0%
100,000
-51.2%
0.35%
-55.8%
Q1 2019$22,931,000
+35.4%
205,000
+22.0%
0.79%
+5.2%
Q4 2018$16,933,000168,0000.75%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 185,781$4,611,56512.16%
Samsara BioCapital, LLC 640,688$11,878,3563.64%
ALPINE ASSOCIATES MANAGEMENT INC. 2,203,295$40,849,0892.14%
Versor Investments LP 378,480$7,017,0191.42%
Magnetar Financial LLC 2,407,209$44,629,6551.14%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,077,893$38,524,1360.85%
Fort Baker Capital Management LP 430,600$7,983,3240.74%
EHP Funds Inc. 84,210$1,561,2530.73%
Terrapin Asset Management, LLC 30,000$556,2000.63%
AQR Arbitrage LLC 734,970$13,626,3440.61%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders